CorMedix Inc. (CRMD) stock is up 10.80% over the past week and gets a Neutral rating from InvestorsObserver's Sentiment Indicator.
What is Stock Sentiment?
In investing, sentiment generally means whether or not a given security is in favor with investors. It is typically a pretty short-term metric that relies entirely on technical analysis. That means it doesn’t incorporate anything to do with the health or profitability of the underlying company.
Recent trends are a good indicator of current market sentiments. In its most basic form, stocks that are trending up are desirable by investors while stocks currently falling must be unattractive.
InvestorsObserver's Sentimental Indicator tracks both changes in price and volume to analyze the most recent trends. Typically an increase in volume indicates ongoing trends are getting stronger, while a decrease in volume usually signals an end to the current trend.
Available options can also represent current sentiments for a given stock. Since investors are able to bet on future trends of stocks using options, we consider the ratio of calls to puts when analyzing market sentiments .
What's Happening With CRMD Stock Today?
CorMedix Inc. (CRMD) stock is up 5.93% while the S&P 500 is lower by -0.03% as of 10:48 AM on Monday, Nov 9. CRMD has risen $0.31 from the previous closing price of $5.23 on volume of 76,389 shares. Over the past year the S&P 500 is up 13.68% while CRMD has risen 1.65%. CRMD lost -$1.91 per share in the over the last 12 months.
To screen for more stocks like CorMedix Inc. click here.
More About CorMedix Inc.
Cormedix Inc is a biopharmaceutical company which focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. It has in-licensed to develop and commercialize Neutrolin, which is a novel anti-infective solution or the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings such as dialysis, critical/intensive care, and oncology. The Neutrolin product is designed to target unmet medical need.
Click Here to get the full Stock Score Report on CorMedix Inc. (CRMD) Stock.